DA
GBIO

Denali Advisors’s Generation Bio GBIO Stock Holding History

Denali Advisors’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,060
Closed -$40.2K – 473
2023
Q3 		$40.2K Hold
1,060
– – 0.01% 302
2023
Q2 		$58.3K Hold
1,060
– – 0.02% 286
2023
Q1 		$45.6K Hold
1,060
– – 0.02% 230
2022
Q4 		$41.7K Buy
1,060
+320
+43% +$16.8K 0.02% 249
2022
Q3 		$39K Buy
+740
New +$46.3K 0.02% 239

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Denali Advisors's GBIO Position: Q4 2023 in Review

Denali Advisors sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 1,060 shares — an estimated $40.2K sold.

Denali Advisors first reported a position in GBIO in Q3 2022 and held it in 5 quarters. The position peaked at $58.3K in Q2 2023. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • Denali Advisors reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • Denali Advisors sold 1,060 Generation Bio shares in Q4 2023, an estimated $40.2K.
  • Denali Advisors first reported a position in Generation Bio in Q3 2022 and held it in 5 quarters.
  • Denali Advisors's Generation Bio position peaked at $58.3K in Q2 2023.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on Denali Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.